Full Access
Parkinson's disease epidemiology in the Northampton District, England, 1992
R. L. G. Sutcliffe, J. R. Meara,
Corresponding Author
J. R. Meara
Northamptonshire Health Authority, England
J. R. Meara, Department of Public Health Medicine, Highfield, Cliftonville Road, Northampton NN1 5DN, EnglandSearch for more papers by this authorR. L. G. Sutcliffe, J. R. Meara,
Corresponding Author
J. R. Meara
Northamptonshire Health Authority, England
J. R. Meara, Department of Public Health Medicine, Highfield, Cliftonville Road, Northampton NN1 5DN, EnglandSearch for more papers by this authorAbstract
In a population of 302, 000, in a Midlands district of England, the estimated prevalence of idiopathic Parkinson's disease (IPD) increased from 108 to 121 per 100, 000 from 1982 to 1992. Individual general practice prevalence ranged quite widely. Webster ratings were significantly more often scored in 1992, but at a lower level of severity, suggesting earlier diagnosis. Incidence in 1992 was estimated as 12 per 100, 000 per annum. Micrographia, when copying interlocking pentagons, was significantly related to Hoehn & Yahr scores. Over the 10-year period, there has been a considerable change in prescribing: a positive response to medication was confirmed as a good diagnostic indicator. Progression of symptoms and an increase of physical disability was noted in those of the 1982 study alive in 1992.
Reference
- 1 Sutcliffe RLG, Prior R, B Mawby, McQuillan W J., Parkinson's disease in the District of the Northampton H.A. - Acta Neurol Scand 1985: 72: 363–379.
- 2 Donaldson L. Registering a need. Br Med J 1992: 305: 597–598.
- 3 Koller W, RN Vetere-Overfield, Gray C. et al. Environmental risk factors in Parkinson's disease. Neurology 1990: 40: 1218–1221.
- 4 Department of public health medicine, Northamptonshire health authority. The health of the population of Northamptonshire 1982.
- 5 OPCS Census 1991. County report, Northamptonshire, Part 1. HMSO 1992.
- 6 Dept of Health NHS Management Executive. A guide to consent for examination or treatment 1990. HC (90) and handbook.
- 7 Webster DD. Clinical analysis of the disability in Parkinson's disease. Mod Treat 1968: 5: 257–328.
- 8 Hoehn MM, MD Yahr, Parkinsonism: onset, progression and mortality. Neurology 1967: 17: 427–442.
- 9 Folstein MJ, SE Folstein, McHugh PR. Mini-mental state. A practical grading for cognitive state of patients for the clinician. J Psychiatr Res 1975: 12: 189–98.
- 10 Canter CJ. De la Torre R. Mier M. A method of evaluating disability in patients with Parkinson's disease. J Nerv Ment Dis 1961: 133: 143–147.
- 11 Gibb WRG, AJ Lees, The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropath Appl Neurobiol 1989: 15: 27–44.
- 12 Kurland LT. Epidemiology: incidence, geographic distribution and genetic considerations. Pathogenesis and treatment of parkinsonism. WS Shields, ed. Springfield : CC Thomas. 1958: 5–49.
- 13 Hoehn MM. Age distribution of patients with Parkinsonism. J Am Geriatr Soc 1976: 24: 79–85.
- 14 Duvoisin RC. Is Parkinson's disease acquired or inherited Can J Neurol Sci 1984: 11: 151–155.
- 15 Ebmier KP. Mutch WJ. Calder SA, Crawford JR, Stewart L. Besson JOA. Does idiopathic Parkinsonism in Aberdeen follow intra-uterine influenza J Neurol Neurosurg Psychiatry 1989: 52: 911–913.
- 16 Mattock C, M Marmot Stern G. Could Parkinson's disease follow intra-uterine influenza? A speculative hypothesis. J Neurol Neurosurg Psychiatry 1988: 51: 753–756.
- 17 O'Callaghan E, Shap P, N Takei Glover G, Mar-ray RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991: 337: 1248–1250.
- 18 Selten JP. CJ. Slaets JPJ. Evidence against maternal influenza as a risk factor for schizophrenia. Br J Psychiatry 1994: 164: 674–676.
- 19 OPCS Standard occupational classification, major group codes HMSO 1990.
- 20 Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson's disease in a Japanese City. Acta Neurol 1983: 40: 151–154.
- 21 Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, ROY SR. Parkinson's disease in a Scottish City. Br Med J 1986: 292: 534–536.
- 22 Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's disease in Benghazi, North East Libya. Clin Neurol Neurosurg 1986: 88-2: 109–113.
- 23 ĎAlessandro R, Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli D. Prevalence of Parkinson's disease in the Republic of San Marino. Neurol 1987: 37: 1679–1682.
- 24 Casetta I, Granieri E, Govoni V et al., Epidemiology of Parkinson's disease in Italy. Descriptive survey in the USL of Cento. Acta Neurol 1990: 12: 284–291.
- 25 Vieregge P, Kleinhenz J, Fassl H, Jorg J, Kompf D. Epidemiology and outpatient case in Parkinson's disease -results from a pilot study in northern Germany (Schleswig-Holstein). J Neurol Transm 1991 (suppl.) 33: 115–118.
- 26 Rocca WA, Morgante L, Grigoletto F, et al. Prevalence of Parkinson's disease and other Parkinsonisms: a door-to-door survey in 2 Sicilian communities. Neurol 1990 (suppl.) 422.
- 27 Hofman A, Collette HJA, Bartelds AIM. Incidence and risk factors of Parkinson's disease in the Netherlands. Neuroepidemiology 1989: 8: 296–299.
- 28 De Pedro Cuesta J. Parkinson's disease occurance in Europe. Acta Neurol Scand 1991: 84(4): 357–365.
- 29 Martilla RJ, Rinne UK. Epidemiological approaches to the etiology of Parkinson's disease. Acta Neurol Scand 1989: 126: 13–18.
- 30 Godwin-Austen RB, Lowe J. The two types of Parkinson's disease. Parkinson's Disease Clin Exper Adv. Rose FC ed. 1987.
- 31 Chio' A, Magnani C, Tolardo G, Schiffer D. Parkinson's disease mortality in Italy 1951 through 1987. Analysis of an increasing trend Arch Neurol 1993: 50: 149–153.
- 32 Barbeau A, Pourcher E. New data on the genetics of Parkinson's disease. Can J Neurol Sci 1982: 9: 53–60.
- 33 Ward CD, Duvoisin RC, Ince SE et al., Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983: 33: 815–24.
- 34 Martilla RJ, Kaprio J, Koskenvuo M, Rinne UK. Parkinson's disease in a nationwide twin cohort. Neurology 1988: 38: 1217–1219.
- 35 Smith CAD, Gough AC, Leigh PN et al., Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992: 339: 1375–1377.
- 36
Calne DB,
Langston JW.
Aetiology of Parkinson's disease.
Lancet
1983: ii: 1457–59.
10.1016/S0140-6736(83)90802-4 Google Scholar
- 37 Mena I, Court J, Fuenzauda S et al., Modification of chronic manganese poisoning. N Engl J Med 1970: 282: 5.
- 38 Vigliani EC. Carbon Disulfide poisoning in viscose rayon factories. Br J Indust Med 1954: 11: 235.
- 39 Kisby GE, Ellison M, Spencer PS. Content of neurotoxins cyacin and BMAA in cycad flour prepared by Guam Chamorros. Neurology 1992: 42: 1336–1340.
- 40 Duncan MW, Marini AM, Watters SR, Kopin IJ, Markey SP. Zinc, a neurotoxin to cultured neuron, contaminates cycad flour prepared by traditional Guamanian methods. J Neurosci 1992: 12: 1523–1537.
- 41 Forno LS, Langston JW, Delanney LE, et al. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 1986: Oct. 20 4: 449–58.
- 42 Jenner P, Dexter DT, Sian J, Schapira AHV, Mars-den CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 1992: 32: S82–S87.
- 43 Jenner P, Schapira AHV, Marsden CD. New insights into the cause of Parkinson's disease. Neurology 1992: 42: 2241–2250.
